In hepatocellular carcinoma, tumor cells and TAN work together to activate neutrophils in peripheral blood of patients, secrete chemokine CC motif ligand 2 (CCL2) and chemokine CC motif ligand 17 (CCL17), and then promote tumor growth, proliferation, and macrophage growth. The gene discussed is CCL2; the disease is neoplasm.